Identification of the molecular mechanisms of non-response to treatments, relapses and remission in autoimmune, inflammatory, and allergic conditions
Project factsheets
Learn more about the projects supported by IHI as well as the Innovative Medicines Initiative (IMI).
Displaying 37 projects and 0 programmes
Accelerating research & development for advanced therapies
Collaboration for prevention and treatment of MDR bacterial infections
Development of Robust and Innovative Vaccine Effectiveness
EBiSC2 – A sustainable European bank for induced pluripotent stem cells
Communication strategy and tools for optimizing the impact of Ebola vaccination deployment
European Platform for Neurodegenerative Diseases
European Quality In Preclinical Data
Investigating mechanisms and models predictive of accessibility of therapeutics (IM2PACT) into the brain
Improving the care of patients suffering from acute or chronic pain
Integrated immunoprofiling of large adaptive cancer patients cohorts
Better control and treatment of immune-mediated diseases by exploring the universe of microenvironment imposed tissue signatures and their correlates in liquid biopsies
Innovations to accelerate vaccine development and manufacture
Liver Investigation: Testing Marker Utility in Steatohepatitis
Intermediate AMD: development of novel clinical endpoints for clinical trials in patients with a regulatory and patient access intention
Machine learning ledger orchestration for drug discovery
Connecting digital mobility assessment to clinical outcomes for regulatory and clinical endorsement
New clinical endpoints in primary Sjögren’s syndrome: an interventional trial based on stratifying patients
PD-MitoQUANT – A quantitative approach towards the characterisation of mitochondrial dysfunction in Parkinson's disease
Research empowerment on solute carriers
Add medical genetic solutions to RESOLUTE (REsolution)
Rheuma Tolerance for Cure
Accelerating development and improving access to CAR and TCR-engineered T cell therapy
Translational quantitative systems toxicology to improve the understanding of the safety of medicines
Imaging biomarkers (IBs) for safer drugs: validation of translational imaging methods in drug safety assessment
Vaccines and infectious diseases in the ageing population
Vaccine safety and immunogenicity signatures of human responses to VSV-ZEBOV
Anti-Biopharmaceutical Immunization: Prediction and Analysis of Clinical Relevance to Minimize the Risk
Biomarkers for Enhanced Vaccine Immunosafety
Cancer treatment and monitoring through identification of circulating tumour cells and tumour related nucleic acids in blood
Drug Disease Model Resources
Integrating bioinformatics and chemoinformatics approaches for the development of Expert systems allowing the in silico prediction of toxicities
Kinetics for Drug Discovery
Biomarkers and molecular tumour classification for non-genotoxic carcinogenesis
Pharmacoepidemiological research on outcomes of therapeutics by a European consortium
Safer and Faster Evidence-based Translation
Recognising Adverse Drug Reactions
